The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
PD Subtypes, 2007Phenoprofiling PD
Parkinson's disease is generally characterized as a movement disorder. Over the last years, however, there has been an increasing awareness that many people with PD may also suffer so-called "non...
-
PD Subtypes, 2007Do Clinical Characteristics at PD Diagnosis Predict Survival?
Tremendous efforts have been directed toward the identification of factors that affect the progression of Parkinson's disease, yet to date few factors have been identified. Most studies seeking to...
-
PD Subtypes, 2007Prognostic factors in early Parkinson’s disease
The progression of Parkinson’s disease is highly variable from patient to patient. It is currently not possible to predict the future course of Parkinson’s disease from early physical signs or...
-
PD Subtypes, 2007Longitudinal changes in patterns of motor UPDRS subscore
Tremor, bradykinesia (slowness of movement), rigidity (stiffness) and walking/balance impairment are the major signs of Parkinson's disease; a middle-age onset with slow progression is archetypal...
-
PD Subtypes, 2007Prediction of Death, Dementia, Disability, Depression from the Time Course of UPDRS Motor Status
Parkinson’s disease is progressive. Early on, its effects are relatively minor, affecting mainly movement and causing shaking of the limbs. Later on, serious events -- early death, dementia...
-
PD Subtypes, 2007Defining PD Subtypes Based on Patterns of Long-term Outcome
The purpose of our study is to identify Parkinson’s disease subtypes based on how individuals are doing approximately seven to eight years after diagnosis. Some patients have few symptoms at this time...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.